For Year 2025-26, Vanta Bioscience reports the following shareholding: Total Promoters at 72.81%, Mutual Fund at 0%, Insurance at 0%, Foreign Institutional Investors at 0%, Domestic Institutional Investors at 0%, and Retail at 27.19%. This breakdown provides a quick snapshot of ownership distribution for Vanta Bioscience in 2025-26.